Call To Learn Your Options
Request your free & confidential consultation

Defective Breast Mesh Lawyer

Internal Bra Mesh Lawsuit: Help for Women Injured by Breast Mesh

Medically & legally reviewed for accuracy ·
Last updated: June 2026

The short answer: Women who had surgical mesh (an “internal bra”)
placed during breast reconstruction, augmentation, or revision surgery and later
developed complications may be able to file a breast mesh lawsuit. The claims allege
that manufacturers promoted these devices for breast surgery even though
no surgical mesh is FDA-approved or cleared for use in the breast.
Consultations are free and confidential.
Speak with someone who understands what you’re going through.
1-866-659-3020
Free, confidential case review · No fee unless you recover.
Request a review online →

If you were told your breast surgery used an “internal bra” — or you’ve since
struggled with infection, chronic pain, hardening, or a return to the operating
room — you may have been affected by a product that was never tested or approved
for use in the breast. This page explains, in plain language, what the litigation
is about, who may qualify, what can go wrong, and what to do next. It’s written for
the woman trying to make sense of all this, not for lawyers.

What is an “internal bra,” and why are women suing?

An “internal bra” is a surgical technique that uses mesh implanted inside the breast
to support tissue and implants from within — much like a bra supports the breast from
outside. Women are suing because manufacturers marketed this mesh for breast
procedures it was never FDA-approved for, and many patients say they were never warned
about the risks.

The mesh is positioned beneath or over the breast tissue to provide structural support.
Surgeons use it in three main settings:

  • Breast reconstruction after a mastectomy, often following a cancer diagnosis.
  • Breast augmentation, where mesh helps support implants and hold shape over time.
  • Revision or breast lift surgery, to correct or improve a prior procedure.

There are two broad categories of breast mesh:

  • Biologic mesh (ADM): Acellular dermal matrix made from processed human
    or animal tissue that the body gradually incorporates. Common brands include AlloDerm
    and Strattice (porcine).
  • Synthetic mesh: Made from man-made polymers — either resorbable
    (dissolves over months) or permanent. Products seen in this litigation include
    GalaFLEX, Phasix, DuraSorb, and SurgiMend.

Mesh was marketed as a way to reduce stress on surrounding tissue and extend the
longevity of surgical results. The problem: no mesh product has been approved by the
FDA for use in breast surgery, and studies have found complication rates that
manufacturers did not adequately disclose.

Is surgical mesh FDA-approved for breast surgery?

No. As of 2026, no surgical mesh product — biologic or synthetic — is cleared or
approved by the FDA for breast reconstruction, augmentation, or internal bra procedures.
These devices reached operating rooms through the FDA’s 510(k) clearance pathway, which
only requires showing a product is “substantially equivalent” to an existing device and
does not require proof of safety or effectiveness for breast surgery.

The 510(k) pathway is at the heart of many product liability cases. Mesh products were
cleared for general soft-tissue reinforcement — a broad category that has never
been formally extended to the breast. Despite that, sales representatives attended
surgical conferences, marketing materials depicted breast applications, and surgeons were
encouraged to adopt mesh in techniques the FDA had never reviewed. Most patients had no
way of knowing the device placed inside them was being used outside its cleared purpose.

The core allegations

  • Manufacturers failed to run adequate studies on mesh safety in breast-specific uses.
  • They failed to warn surgeons and patients that the products were not cleared for the breast.
  • They actively promoted off-label breast use while patients assumed the products had been properly vetted.
  • They concealed or understated complication rates that were higher than disclosed.

Most cases rest on failure-to-warn and defective design
claims, with some adding negligence and fraud depending on the facts.

FDA warnings on breast mesh: a timeline

Year What happened
2021 The FDA issued a safety communication naming FlexHD and AlloMax (two acellular
dermal matrix products), warning of significantly higher complication rates in
implant-based breast reconstruction. No recall was issued, and women who had
already received these products were not directly notified.
2023 In a November letter to health care providers, the FDA required Becton, Dickinson
and Company (BD) to update labels on GalaFLEX, Phasix, and related products. For
the first time, the labels stated the devices were not studied or cleared for breast
surgery, and that the benefit-risk profile for breast use remains undefined.
2025 Members of the medical community began raising public concerns about internal bra
procedures, including a former BD medical director who has alleged that internal
safety concerns were not adequately reported to the FDA.
2026 Still no breast mesh product holds FDA approval for breast surgery. Cases are being
filed and investigated individually; there is no certified class action or
multidistrict litigation (MDL) yet, though consolidation is possible as claims grow.

Why the timeline matters: the 2023 label updates were a formal acknowledgment, years in
the making, that these products were being used in a context they were never validated
for. They offer little comfort to a woman who had surgery in 2018, 2019, or 2020 without
that information. The central question in this litigation is what manufacturers knew, when
they knew it, and why it took so long to appear on a warning label.

Which breast mesh brands are under legal investigation?

The following products are under active legal scrutiny. Named manufacturers include
Allergan/LifeCell, Becton Dickinson (BD), C.R. Bard, Integra LifeSciences, and
MTF Biologics. If your surgery involved any of these, it’s worth having your records
reviewed.

Brand / Type Manufacturer FDA status
AlloDerm — ADM, human Allergan / LifeCell Not approved for breast surgery
Strattice — ADM, porcine Allergan / LifeCell Not approved for breast surgery
GalaFLEX — synthetic, P4HB Galatea Surgical / BD Label updated Nov. 2023; not approved for breast
Phasix — synthetic, P4HB C.R. Bard / BD Label updated Nov. 2023; not approved for breast
DuraSorb — synthetic, PDO Integra LifeSciences Not approved for breast surgery
SurgiMend — ADM, bovine Integra LifeSciences Not approved for breast surgery
AlloMax — ADM, human C.R. Bard / BD FDA warning 2021 — elevated complication rate
FlexHD — ADM, human MTF Biologics FDA warning 2021 — elevated complication rate

This list isn’t exhaustive. If your mesh brand isn’t here, you may still have a valid
claim — an attorney can review your records and tell you whether your specific product
and injuries qualify.

Do I qualify to file an internal bra mesh lawsuit?

You may qualify if you had breast reconstruction, augmentation, or revision surgery in
which mesh or ADM was used, and you later experienced complications. You do not need to
have had the mesh removed, and you don’t need every detail figured out before talking to
someone.

You may have a claim if all of the following are true:

  1. You had breast reconstruction, augmentation, or revision surgery —
    including reconstruction after a mastectomy, augmentation with implants, or a revision
    or breast lift.
  2. Surgical mesh or ADM was used. It may have been biologic, synthetic,
    resorbable, or permanent. If you’re not sure, your surgical records will identify it,
    and an attorney can help you obtain them.
  3. You experienced complications afterward — such as infection, seroma,
    mesh failure, chronic pain, breast deformity, capsular contracture, implant loss, or
    the need for revision surgery.
  4. You’re still within your state’s filing deadline. Statutes of
    limitations vary, often one to six years from the date of injury or the date you
    discovered it was linked to the mesh.

A note on what firms are accepting: many attorneys are currently prioritizing cases that
involved a revision surgery or another serious, well-documented injury. Even if you’re
unsure where you fall, a free review can clarify it quickly.

What can go wrong with internal bra mesh?

The body doesn’t always tolerate foreign material. Whether biologic or synthetic, mesh
can trigger a reaction — sometimes within weeks, sometimes months or years later. One
2024 study in the Aesthetic Surgery Journal Open Forum found reoperation rates
as high as 10% in patients who received mesh during breast procedures, with the implant
lost entirely in about 3% of synthetic-mesh reconstruction patients.

Complication What it means
Infection & abscess Deep infections that resist antibiotics and often require surgical removal of the mesh.
Seroma Chronic fluid buildup around the mesh or implant, requiring repeated drainage and monitoring.
Capsular contracture Scar tissue hardens around the implant, causing progressive pain and visible deformity.
Mesh migration or failure The mesh shifts from position or detaches from the tissue it was meant to support.
Skin erosion & tissue necrosis In severe cases the mesh wears through tissue, causing permanent tissue death.
Chronic pain & nerve injury Persistent pain, numbness, or hypersensitivity in the breast or chest wall.
Implant loss The implant must be removed entirely due to infection, contracture, or mesh failure.

How do I find out if mesh was used in my surgery?

Request your complete operative report from the hospital or surgical center — it lists
every material implanted, including mesh. You can also look for device implant stickers
in your records, check discharge paperwork, or call your surgeon’s office directly. An
attorney can obtain these records for you if that feels overwhelming.

Many women are never explicitly told that mesh was part of their procedure. To find out:

  • Request your operative report. This describes exactly what was done and what was implanted.
  • Look for device implant stickers. Hospitals attach product stickers with the brand, product code, and Unique Device Identifier (UDI) to your record.
  • Review discharge paperwork and implant cards given to you at surgery — a shortcut, but not essential if you’ve lost them.
  • Call your surgeon’s office and ask directly whether mesh or ADM was used, and which brand.

Your medical records belong to you by law. If a provider creates obstacles, an attorney
can issue a formal records request on your behalf.

What evidence strengthens a breast mesh claim?

You don’t need everything assembled before talking to someone, but gathering what you can helps:

Medical records

  • Operative reports from the original surgery
  • Device implant logs with brand, model, and lot number
  • Imaging (MRI, ultrasound) and pathology reports
  • Follow-up notes documenting complications
  • Records of any revision or removal procedures

Financial & personal records

  • Medical bills, pharmacy receipts, out-of-pocket costs
  • Documentation of lost wages or reduced work capacity
  • A personal journal of symptoms and daily limitations
  • Photographs of visible injuries or physical changes
  • Statements from family members or caregivers

Many women wait because they’re still in treatment or unsure their situation “counts.”
That hesitation is understandable, but evidence fades and filing deadlines pass. You do
not need a complete file to have a conversation.

How much is a breast mesh lawsuit worth?

It’s too early for firm figures. As of 2026 there are no large-scale breast mesh
settlements yet, because the litigation is still developing. Comparable mesh litigation
offers context: in 2024, C.R. Bard reached a settlement estimated at more than
$1 billion to resolve roughly 40,000 hernia mesh claims.

Bard now faces scrutiny over breast mesh products including AlloMax and Phasix. While
hernia and breast cases involve different injuries, that precedent shows mesh
manufacturers have faced and resolved major liability for off-label harm. The value of
any individual claim depends on several factors:

Factor How it affects value
Severity of injury Permanent deformity, tissue necrosis, and implant loss generally yield more than temporary complications.
Revision or removal surgery Cases requiring additional operations typically carry higher damages.
Duration of suffering Longer periods of chronic pain or diminished quality of life increase value.
Documented medical costs Surgeries, medications, therapy, and out-of-pocket costs are recoverable.
Lost income Lost wages and reduced earning capacity factor into total damages.
Pain and suffering Non-economic damages for physical pain, emotional distress, and loss of enjoyment of life.

The clearest picture of value will come once attorneys review the manufacturers’ internal
documents. If cases consolidate into coordinated proceedings, “bellwether” test trials
typically help establish settlement ranges — a process that often takes two to three years.

Frequently asked questions

Is surgical mesh FDA-approved for breast surgery?

No. Not a single mesh product — biologic ADM or synthetic — has been approved by the
FDA for use in breast surgery. The products were cleared under the 510(k) pathway for
general soft-tissue repair, and that clearance has never been extended to
breast-specific procedures.

What if my mesh was resorbable — can I still file?

Yes. Resorbable mesh dissolves over time, but complications such as infection, seroma,
and tissue reactions can still occur. The fact that the material has since dissolved
does not extinguish your right to pursue a claim.

Do I need to have the mesh removed to be eligible?

No. Mesh removal is not required. If you experienced qualifying complications, you may
be eligible whether or not the mesh was removed. That said, many firms are currently
prioritizing cases that involved a revision surgery or another serious injury.

How long do I have to file an internal bra mesh lawsuit?

Deadlines vary by state — typically one to six years, starting from the date you were
injured or the date you discovered (or reasonably should have discovered) that your
injury was linked to the mesh. This “discovery rule” can extend the window for older
injuries, but the statute of limitations is more complicated than it looks. Missing it
permanently bars recovery, so it’s worth confirming your deadline early.

My surgeon told me the mesh was safe. Does that hurt my case?

Not necessarily — it may actually help. Surgeons often had no reason to doubt these
products because manufacturers didn’t provide adequate breast-specific warnings, and
many surgeons were themselves misled by marketing implying broader clearance than the
products held. The legal claims are aimed primarily at manufacturers, not treating
physicians.

What does it cost to speak with a breast mesh attorney?

Nothing. These cases are handled on a contingency-fee basis, meaning you pay no legal
fees unless your case results in a recovery. An initial case review is free and carries
no obligation.

Is there a breast mesh class action or MDL yet?

As of 2026, there is no certified class action or multidistrict litigation (MDL).
Cases are being filed and investigated individually, though consolidation into a
coordinated proceeding is possible as the number of claims grows.

Request a free, confidential case review

Prefer to talk now? Call
866-659-3020
Available 24/7 · Free · No obligation
If you prefer to fill out a consultation request form, please use the form below.